PERKINELMER INC (PKI)
US7140461093 - Common Stock
Bitcoin Now Buys You the Greatest Amount of Revvity in the Past Year
Revvity down as 2023 guidance misses consensus (NYSE:PKI)
Revvity (PKI) is down 5% in Thursday afternoon trading after its 2023 guidance ranges for EPS and revenue missed consensus estimates. Read more here.
PerkinElmer Enters Oversold Territory (PKI)
S&P 500 Movers: DIS, TPR
PerkinElmer Non-GAAP EPS of $1.01 misses by $0.01, revenue of $674.86M misses by $3.75M (NYSE:PKI)
PerkinElmer press release (PKI): Q1 Non-GAAP EPS of $1.01 misses by $0.01.Revenue of $674.86M (-29.9% Y/Y) misses by $3.75M.The company’s stock ticker will change from PKI to RVTY...
Revvity Announces Financial Results for the First Quarter of 2023
Launching Revvity: A Scientific Solutions Company Powering Innovation from Discovery to Cure
PerkinElmer declares $0.07 dividend (NYSE:PKI)
PerkinElmer (NYSE:PKI) declares $0.07/share quarterly dividend, in line with previous.Forward yield 0.22%Payable Aug.
PerkinElmer Board Declares Quarterly Dividend
PerkinElmer to Hold Earnings Call on Thursday, May 11, 2023
May 19th Options Now Available For PerkinElmer (PKI)
PerkinElmer Completes Divestiture of its Applied, Food and Enterprise Services Businesses
S&P 500 Analyst Moves: PKI
PerkinElmer to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
PerkinElmer Launches EnVison Nexus Multimode Plate Reader to Drive Improved Research and Discovery Workflows
PerkinElmer to Present at Upcoming Investor Conferences
Interesting PKI Put And Call Options For April 21st
PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year of 2022
PerkinElmer (PKI) Shares Cross Above 200 DMA
PerkinElmer declares $0.07 dividend (NYSE:PKI)
PerkinElmer (NYSE:PKI) declares $0.07/share quarterly dividend, in line with previous.Forward yield 0.21%Payable May 12; for shareholders of record April 21; ex-div April 20.See PKI...
PerkinElmer Board Declares Quarterly Dividend
Danaher earnings weigh on other life sciences tools, services companies (NYSE:PKI)
Danaher (DHR), which reported slowing topline growth in its Q4 2022 financial results earlier Tuesday, is impacting other life sciences tools and services providers.
PerkinElmer Moves Up In Market Cap Rank, Passing Clorox
Interesting PKI Put And Call Options For September 15th
NIH outlays fall, US govt healthcare grants grow but Biopharma financings fall Y/Y
Outlays from the National Institutes of Health ((NIH)) for December 2022 decreased ~4% Y/Y (-35% versus November 2022), according to report from Baird Equity Research.December 2022...
PerkinElmer says Q4 results will meet or exceed prior guidance (NYSE:PKI)
PerkinElmer (PKI) said that it expects its Q4 2022 results to meet or exceed guidance given in November.
